Report Detail
Global Intravenous (IV) Therapy and Vein Access Market Insights, Forecast to 2025
- RnM3526649 |
- 14 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Chemical & Material
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
Global Intravenous (IV) Therapy and Vein Access market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Intravenous (IV) Therapy and Vein Access.
This report researches the worldwide Intravenous (IV) Therapy and Vein Access market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Intravenous (IV) Therapy and Vein Access breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Intravenous (IV) Therapy and Vein Access Breakdown Data by Type
Infusion pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Intravenous (IV) Therapy and Vein Access Breakdown Data by Application
Hospital
Clinics
Other
Intravenous (IV) Therapy and Vein Access Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Intravenous (IV) Therapy and Vein Access Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Intravenous (IV) Therapy and Vein Access capacity, production, value, consumption, status and forecast;
To focus on the key Intravenous (IV) Therapy and Vein Access manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Intravenous (IV) Therapy and Vein Access :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
Global Intravenous (IV) Therapy and Vein Access Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
- 1.1 Intravenous (IV) Therapy and Vein Access Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type
- 1.4.2 Infusion pumps
- 1.4.3 Implantable Ports
- 1.4.4 Intravenous Catheters
- 1.4.5 Hypodermic Needles
- 1.4.6 Other
- 1.5 Market by Application
- 1.5.1 Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinics
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Intravenous (IV) Therapy and Vein Access Production
- 2.1.1 Global Intravenous (IV) Therapy and Vein Access Revenue 2014-2025
- 2.1.2 Global Intravenous (IV) Therapy and Vein Access Production 2014-2025
- 2.1.3 Global Intravenous (IV) Therapy and Vein Access Capacity 2014-2025
- 2.1.4 Global Intravenous (IV) Therapy and Vein Access Marketing Pricing and Trends
- 2.2 Intravenous (IV) Therapy and Vein Access Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Intravenous (IV) Therapy and Vein Access Manufacturers
- 2.4 Market Drivers, Trends and Issues
- 2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
- 3.1 Intravenous (IV) Therapy and Vein Access Production by Manufacturers
- 3.1.1 Intravenous (IV) Therapy and Vein Access Production by Manufacturers
- 3.1.2 Intravenous (IV) Therapy and Vein Access Production Market Share by Manufacturers
- 3.2 Intravenous (IV) Therapy and Vein Access Revenue by Manufacturers
- 3.2.1 Intravenous (IV) Therapy and Vein Access Revenue by Manufacturers (2014-2019)
- 3.2.2 Intravenous (IV) Therapy and Vein Access Revenue Share by Manufacturers (2014-2019)
- 3.3 Intravenous (IV) Therapy and Vein Access Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Intravenous (IV) Therapy and Vein Access Production by Regions
- 4.1 Global Intravenous (IV) Therapy and Vein Access Production by Regions
- 4.1.1 Global Intravenous (IV) Therapy and Vein Access Production Market Share by Regions
- 4.1.2 Global Intravenous (IV) Therapy and Vein Access Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States Intravenous (IV) Therapy and Vein Access Production
- 4.2.2 United States Intravenous (IV) Therapy and Vein Access Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Intravenous (IV) Therapy and Vein Access Import & Export
- 4.3 Europe
- 4.3.1 Europe Intravenous (IV) Therapy and Vein Access Production
- 4.3.2 Europe Intravenous (IV) Therapy and Vein Access Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Intravenous (IV) Therapy and Vein Access Import & Export
- 4.4 China
- 4.4.1 China Intravenous (IV) Therapy and Vein Access Production
- 4.4.2 China Intravenous (IV) Therapy and Vein Access Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Intravenous (IV) Therapy and Vein Access Import & Export
- 4.5 Japan
- 4.5.1 Japan Intravenous (IV) Therapy and Vein Access Production
- 4.5.2 Japan Intravenous (IV) Therapy and Vein Access Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Intravenous (IV) Therapy and Vein Access Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 Intravenous (IV) Therapy and Vein Access Consumption by Regions
- 5.1 Global Intravenous (IV) Therapy and Vein Access Consumption by Regions
- 5.1.1 Global Intravenous (IV) Therapy and Vein Access Consumption by Regions
- 5.1.2 Global Intravenous (IV) Therapy and Vein Access Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America Intravenous (IV) Therapy and Vein Access Consumption by Application
- 5.2.2 North America Intravenous (IV) Therapy and Vein Access Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe Intravenous (IV) Therapy and Vein Access Consumption by Application
- 5.3.2 Europe Intravenous (IV) Therapy and Vein Access Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Intravenous (IV) Therapy and Vein Access Consumption by Application
- 5.4.2 Asia Pacific Intravenous (IV) Therapy and Vein Access Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Intravenous (IV) Therapy and Vein Access Consumption by Application
- 5.5.2 Central & South America Intravenous (IV) Therapy and Vein Access Consumption by Countries
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Intravenous (IV) Therapy and Vein Access Consumption by Application
- 5.6.2 Middle East and Africa Intravenous (IV) Therapy and Vein Access Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa
6 Market Size by Type
- 6.1 Global Intravenous (IV) Therapy and Vein Access Breakdown Dada by Type
- 6.2 Global Intravenous (IV) Therapy and Vein Access Revenue by Type
- 6.3 Intravenous (IV) Therapy and Vein Access Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global Intravenous (IV) Therapy and Vein Access Breakdown Dada by Application
- 7.2.1 Global Intravenous (IV) Therapy and Vein Access Consumption by Application
- 7.2.2 Global Intravenous (IV) Therapy and Vein Access Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 B. Braun
- 8.1.1 B. Braun Company Details
- 8.1.2 Company Description
- 8.1.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.1.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.1.5 SWOT Analysis
- 8.2 Baxter International
- 8.2.1 Baxter International Company Details
- 8.2.2 Company Description
- 8.2.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.2.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.2.5 SWOT Analysis
- 8.3 Becton Dickinson
- 8.3.1 Becton Dickinson Company Details
- 8.3.2 Company Description
- 8.3.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.3.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.3.5 SWOT Analysis
- 8.4 C. R. Bard
- 8.4.1 C. R. Bard Company Details
- 8.4.2 Company Description
- 8.4.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.4.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.4.5 SWOT Analysis
- 8.5 Fresenius Kabi
- 8.5.1 Fresenius Kabi Company Details
- 8.5.2 Company Description
- 8.5.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.5.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.5.5 SWOT Analysis
- 8.6 Hospira(ICU Medical)
- 8.6.1 Hospira(ICU Medical) Company Details
- 8.6.2 Company Description
- 8.6.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.6.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.6.5 SWOT Analysis
- 8.7 Medtronic
- 8.7.1 Medtronic Company Details
- 8.7.2 Company Description
- 8.7.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.7.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.7.5 SWOT Analysis
- 8.8 Smiths Group
- 8.8.1 Smiths Group Company Details
- 8.8.2 Company Description
- 8.8.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.8.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.8.5 SWOT Analysis
- 8.9 Teleflex
- 8.9.1 Teleflex Company Details
- 8.9.2 Company Description
- 8.9.3 Capacity, Production and Value of Intravenous (IV) Therapy and Vein Access
- 8.9.4 Intravenous (IV) Therapy and Vein Access Product Description
- 8.9.5 SWOT Analysis
9 Production Forecasts
- 9.1 Intravenous (IV) Therapy and Vein Access Production and Revenue Forecast
- 9.1.1 Global Intravenous (IV) Therapy and Vein Access Production Forecast 2019-2025
- 9.1.2 Global Intravenous (IV) Therapy and Vein Access Revenue Forecast 2019-2025
- 9.2 Intravenous (IV) Therapy and Vein Access Production and Revenue Forecast by Regions
- 9.2.1 Global Intravenous (IV) Therapy and Vein Access Revenue Forecast by Regions
- 9.2.2 Global Intravenous (IV) Therapy and Vein Access Production Forecast by Regions
- 9.3 Intravenous (IV) Therapy and Vein Access Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global Intravenous (IV) Therapy and Vein Access Production Forecast by Type
- 9.4.2 Global Intravenous (IV) Therapy and Vein Access Revenue Forecast by Type
10 Consumption Forecast
- 10.1 Consumption Forecast by Application
- 10.2 Intravenous (IV) Therapy and Vein Access Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America Intravenous (IV) Therapy and Vein Access Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Intravenous (IV) Therapy and Vein Access Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Intravenous (IV) Therapy and Vein Access Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Intravenous (IV) Therapy and Vein Access Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Intravenous (IV) Therapy and Vein Access Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
- 11.1 Analysis of Intravenous (IV) Therapy and Vein Access Upstream Market
- 11.1.1 Intravenous (IV) Therapy and Vein Access Key Raw Material
- 11.1.2 Typical Suppliers of Key Intravenous (IV) Therapy and Vein Access Raw Material
- 11.1.3 Intravenous (IV) Therapy and Vein Access Raw Material Market Concentration Rate
- 11.2 Intravenous (IV) Therapy and Vein Access Industry Chain Analysis
- 11.3 Marketing & Distribution
- 11.4 Intravenous (IV) Therapy and Vein Access Distributors
- 11.5 Intravenous (IV) Therapy and Vein Access Customers
12 Opportunities & Challenges, Threat and Affecting Factors
- 12.1 Market Opportunities
- 12.2 Market Challenges
- 12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Intravenous (IV) Therapy and Vein Access. Industry analysis & Market Report on Intravenous (IV) Therapy and Vein Access is a syndicated market report, published as Global Intravenous (IV) Therapy and Vein Access Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Intravenous (IV) Therapy and Vein Access market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
